• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[年龄相关性黄斑变性与遗传学]

[Age-related macular degeneration and genetics].

作者信息

Souied E, Kaplan J, Coscas G, Soubrane G

机构信息

Clinique Ophtalmologique Universitaire de Créteil, Université Paris XII, 40, avenue de Verdun, 94010 Créteil, France.

出版信息

J Fr Ophtalmol. 2001 Oct;24(8):875-85.

PMID:11894541
Abstract

Age related macular degeneration (AMD) is the main cause of blindness after age 55 in western countries. These last past years, several lines of evidence such as familial aggregation or twin studies suggested a genetic component in AMD. However, the late onset of the disease and the fact that AMD is a polygenic and multifactorial disease are the main limiting factors for linkage studies. Gene candidate strategy allowed the exclusion of several genes (VMD2, RDS, TIMP3) and lead to the implication of two genetic factors: the apoE gene (involved in the transport of lipids) and the ABCR gene (involved in Stargardt macular dystrophy). Concerning the apoE gene, a lower frequency of the epsilon 4 alleles carriers was observed in the exudative AMD population compared with controls, supporting the idea of a role of the apoE gene in exudative AMD with drusen. These results, together with ultrastructural studies, suggest that allele epsilon 4 is a protective factor for drusen and thus for AMD. For the ABCR gene, several studies and a large multicentric study definitively show that some heterozygous mutations are predisposing factors for AMD, in a polygenic and multifactorial model.

摘要

年龄相关性黄斑变性(AMD)是西方国家55岁以后失明的主要原因。在过去几年中,家族聚集性或双胞胎研究等一系列证据表明AMD存在遗传因素。然而,该疾病的迟发性以及AMD是一种多基因和多因素疾病这一事实,是连锁研究的主要限制因素。候选基因策略排除了几个基因(VMD2、RDS、TIMP3),并发现了两个遗传因素:载脂蛋白E基因(参与脂质运输)和ABCR基因(参与Stargardt黄斑营养不良)。关于载脂蛋白E基因,与对照组相比,在渗出性AMD人群中观察到ε4等位基因携带者的频率较低,这支持了载脂蛋白E基因在伴有玻璃膜疣的渗出性AMD中起作用的观点。这些结果与超微结构研究一起表明,ε4等位基因是玻璃膜疣以及AMD的保护因素。对于ABCR基因,多项研究和一项大型多中心研究明确表明,在多基因和多因素模型中,一些杂合突变是AMD的易感因素。

相似文献

1
[Age-related macular degeneration and genetics].[年龄相关性黄斑变性与遗传学]
J Fr Ophtalmol. 2001 Oct;24(8):875-85.
2
Exclusion of TIMP3 as a candidate locus in age-related macular degeneration.排除金属蛋白酶组织抑制因子3作为年龄相关性黄斑变性的候选基因座。
Invest Ophthalmol Vis Sci. 1997 May;38(6):1060-5.
3
Joint effects of smoking history and APOE genotypes in age-related macular degeneration.吸烟史与载脂蛋白E基因分型在年龄相关性黄斑变性中的联合作用
Mol Vis. 2005 Nov 4;11:941-9.
4
Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender.载脂蛋白E基因与年龄相关性黄斑变性的关联:家族史、年龄和性别的潜在效应修饰作用
Mol Vis. 2000 Dec 31;6:287-93.
5
[Genetic aspects of age-related macular degeneration].[年龄相关性黄斑变性的遗传学方面]
Klin Oczna. 2009;111(4-6):178-82.
6
PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population.PLEKHA1-LOC387715-HTRA1基因多态性与法国人群渗出性年龄相关性黄斑变性
Mol Vis. 2007 Nov 26;13:2153-9.
7
Age-related macular degeneration: a perspective on genetic studies.年龄相关性黄斑变性:遗传学研究视角
Eye (Lond). 2008 Jun;22(6):768-76. doi: 10.1038/sj.eye.6702844. Epub 2007 May 11.
8
[Age-related macular degeneration--a complex genetic disease].年龄相关性黄斑变性——一种复杂的遗传性疾病
Klin Oczna. 2008;110(4-6):211-8.
9
Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.年龄相关性黄斑变性的15年累积发病率:比弗迪尔姆眼科研究
Ophthalmology. 2007 Feb;114(2):253-62. doi: 10.1016/j.ophtha.2006.10.040.
10
Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration.VMD2基因的突变与青少年型卵黄样黄斑营养不良(Best病)和成人卵黄样黄斑营养不良相关,但与年龄相关性黄斑变性无关。
Eur J Hum Genet. 2000 Apr;8(4):286-92. doi: 10.1038/sj.ejhg.5200447.

引用本文的文献

1
Comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration. A retrospective case-controlled non-inferiority multiple center study.康柏西普与雷珠单抗治疗新生血管性年龄相关性黄斑变性的有效性和安全性比较。一项回顾性、病例对照、非劣效性、多中心研究。
Eye (Lond). 2018 Feb;32(2):391-399. doi: 10.1038/eye.2017.187. Epub 2017 Sep 22.